KR910000781A - 안트라사이클린 유도체, 이의 제조방법 및 이의 약제로서의 용도 - Google Patents

안트라사이클린 유도체, 이의 제조방법 및 이의 약제로서의 용도 Download PDF

Info

Publication number
KR910000781A
KR910000781A KR1019900008988A KR900008988A KR910000781A KR 910000781 A KR910000781 A KR 910000781A KR 1019900008988 A KR1019900008988 A KR 1019900008988A KR 900008988 A KR900008988 A KR 900008988A KR 910000781 A KR910000781 A KR 910000781A
Authority
KR
South Korea
Prior art keywords
compound
roa
rod
formula
solution
Prior art date
Application number
KR1019900008988A
Other languages
English (en)
Inventor
헤트만 우도
펠하버 한스-볼프람
수카치 디터-안드레아스
페터 크래머 한스
호프만 디터
Original Assignee
벡커, 엔겔하르트
훽스트 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 벡커, 엔겔하르트, 훽스트 아크티엔게젤샤프트 filed Critical 벡커, 엔겔하르트
Publication of KR910000781A publication Critical patent/KR910000781A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/244—Anthraquinone radicals, e.g. sennosides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/56—Preparation of O-glycosides, e.g. glucosides having an oxygen atom of the saccharide radical directly bound to a condensed ring system having three or more carbocyclic rings, e.g. daunomycin, adriamycin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

내용 없음

Description

안트라사이클린 유도체, 이의 제조방법 및 이의 약제로서의 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
제 1 도는 사이토로딘 Z의 NMR 스펙트럼을 나타낸다.
제 2 도는 사이토로딘 Z의 가수분해 생성물의 NMR스펙트럼을 나타낸다.

Claims (5)

  1. 일반식(Ⅰ)의 화합물 및 이의 약리학적으로 허용되는 염.
    상기식에서, R1은 당잔기 Roa 또는 당 Roa-Rod-Rod의 배합물이고, R2은 당 잔기 Roa 이다.
  2. 유럽특허원 제 0,131,181호에 따라, 미생물 균주 Y-11,472(DSM 2658)를 배양하고 균사체 및 배양 여액을 유기 용매를 사용하여 추출함으로써 수득된 사이토로딘 조혼합물을 a) pH 3.0 내지 4.0의 수성 완충용액중에 용해시켜, 생성된 용액을 단계적으로 증가하는 pH치에서 유기 용매를 추출하고, 농축된 추출물로부터 크로마토그래피 정제에 의해 일반식(Ⅰ)의 화합물(R1은 Roa-Rod-Rod 이고 R2은 Roa이다)을 분리하며, b) 임의적으로, 생성된 화합물을 무기산을 사용하여 R1및 R2가 각각 Roa인 일반식(Ⅰ)의 화합물로 가수분해 시킴을 특징으로하여, 제1항의 화합물을 제조하는 방법.
  3. 제2항에 있어서, 단계 a)중에서 수성 완충 용액을 pH6.0.7.0 및 8.0에서 에틸 아세테이트로 단계적으로 추출하는 방법.
  4. 제1항의 화합물을 함유하는 약제.
  5. 세포성장억제 효과를 갖는 약제 제조를 위한 제1항의 화합물의 용도.
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900008988A 1989-06-20 1990-06-19 안트라사이클린 유도체, 이의 제조방법 및 이의 약제로서의 용도 KR910000781A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE39200620 1989-06-20
DE3920062A DE3920062A1 (de) 1989-06-20 1989-06-20 Neue anthracyclin-derivate, ein verfahren zu ihrer herstellung und ihre verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
KR910000781A true KR910000781A (ko) 1991-01-29

Family

ID=6383094

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900008988A KR910000781A (ko) 1989-06-20 1990-06-19 안트라사이클린 유도체, 이의 제조방법 및 이의 약제로서의 용도

Country Status (8)

Country Link
EP (1) EP0403963A3 (ko)
JP (1) JPH0343093A (ko)
KR (1) KR910000781A (ko)
AU (1) AU5761690A (ko)
CA (1) CA2019315A1 (ko)
DE (1) DE3920062A1 (ko)
IE (1) IE902215A1 (ko)
PT (1) PT94406A (ko)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10029433A1 (de) * 2000-06-15 2001-12-20 Bioleads Gmbh Rhodomycinon-Derivate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3323025A1 (de) * 1983-06-25 1985-01-10 Hoechst Ag, 6230 Frankfurt Anthracyclin-derivate, ein mikrobiologisches verfahren zu ihrer herstellung und ihre verwendung als cytostatika
DE3446052A1 (de) * 1984-12-18 1986-07-17 Hoechst Ag, 6230 Frankfurt Anthracyclin-derivate, ein mikrobiologisches verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3712350A1 (de) * 1987-04-11 1988-10-20 Behringwerke Ag Semisynthetische rhodomycine, verfahren zu ihrer herstellung und ihre verwendung als zytostatika

Also Published As

Publication number Publication date
PT94406A (pt) 1991-03-20
DE3920062A1 (de) 1991-01-10
IE902215A1 (en) 1991-01-16
JPH0343093A (ja) 1991-02-25
CA2019315A1 (en) 1990-12-20
AU5761690A (en) 1991-01-03
EP0403963A2 (de) 1990-12-27
EP0403963A3 (de) 1991-09-18

Similar Documents

Publication Publication Date Title
DE3051175C2 (ko)
KR860002576A (ko) 신규 항생 물질 화합물의 제조방법
KR920703597A (ko) 항종양성 물질 be-13793c
KR890009962A (ko) 매뉴마이신 유도체, 이의 제조방법 및 용도
GB1339032A (en) Rabelomycin and processes for its production
KR910000781A (ko) 안트라사이클린 유도체, 이의 제조방법 및 이의 약제로서의 용도
JPS58111689A (ja) 新抗生物質ピロロマイシンｅおよびその製造法
DE3243924C2 (ko)
KR880011168A (ko) 마크로 사이클릭 화합물의 제조방법
US3896002A (en) Production of brefeldin-A
US3697650A (en) Antibiotic sl 3364
US4468458A (en) Two-functional-group-containing terpenoids, processes for the preparation of the same, and anti-ulcer agents containing the same
Ishiyama et al. Deisovalerylblastmycin produced by Streptomyces sp.
KR880008972A (ko) 카르복실산 유도체
KR880007528A (ko) [3s(z)]-2[[[1-(2-아미노-4-티아졸릴)-2-[[2,2-디메틸-4-옥소-1-(술포옥시)-3-아제티디닐]아미노]-2-옥소에틸리덴]아미노]옥시]아세트산의 결정질 염류
US3842092A (en) Sesquicillin
US3310468A (en) Antifungal antibiotic rutamycin and process for the production thereof
US4086268A (en) 2-(2-Amino-4-chlorophenoxy)benzyl alcohol and diacetate derivative
US3803307A (en) Antibiotic sl 21429
Hayakawa et al. Vertisporin, a new antibiotic from Verticimonosporium diffractum
SU680657A3 (ru) Способ получени антибиотика, обладающего антибактериальным действием против грамположительных бактерий
JPS6135988B2 (ko)
US3887564A (en) Antibiotic A-25822 and process for production therof
GB2053917A (en) Lasalocid derivatives
JPH0578322A (ja) 新規抗生物質ｓｆ２７３８物質及びその製造法並びに制癌剤

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid